¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"growth hormone cell adenoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® anti-diuretic hormone; ADH ÇÑ±Û Ç×ÀÌ´¢È£¸£¸ó
¼³¸í   
  ³úÀÇ ¹Ù´Ú¿¡ ºÙ¾îÀִ ȣ¸£¸óÀ» ÁַΠºÐºñÇϴ ÀÛÀº ±â°üÀΠ³úÇϼöü ÈÄ¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÀ¸·Î ÄáÆÏ¿¡¼­ ¼öºÐÀÇ Èí¼ö¸¦ ÃËÁøÇÏ¿© Ã¼³»¿¡ ¼öºÐÀÇ ¾çÀ» ´ÃÀ̴ ¿ªÇÒÀ» ÇÑ´Ù. µ¿½Ã¿¡ Ç÷°üÀ» ¼öÃà½Ã۴ ÀÛ¿ëÀÌ ÀÖ¾î Ç÷¾ÐÀ» »ó½Â½Ã۴ ¿ªÇÒµµ ÇÑ´Ù.
  
  Ç×ÀÌ´¢È£¸£¸ó
  
  Ç×ÀÌ´¢È£¸£¸ó
  
  Ç×ÀÌ´¢È£¸£¸ó
¿µ¹® hormone ÇÑ±Û È£¸£¸ó
¼³¸í   
  È£¸£¸óÀ̶õ Æ¯Á¤ÇÑ ³»ºÐºñ¼±¿¡¼­ »ý¼º, ÀúÀåµÇ¾î ÀÖ´Ù°¡, °ü·ùÇϴ Ç÷¾× ÁßÀ¸·Î ºÐºñµÈ ´ÙÀ½ Ç÷¾×¿¡ ½Ç·Á ¸Ö¸® ¶³¾îÁ® Àִ ǥÀû¼¼Æ÷(È£¸£¸óÀÌ ÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼¼Æ÷)¿¡ À̸£·¯ ±×°÷¿¡¼­ Æ¯Á¤ÇÑ ±â´ÉÀ» ¹ßÈÖÇϴ ¹°ÁúÀ» ¸»ÇÑ´Ù. ³»ºÐºñ»ùÀÌ ¾Æ´Ï´õ¶óµµ ¾î´À ¼¼Æ÷³ª ¼¼Æ÷±º¿¡¼­ ¼¼Æ÷¿Ü¾× ÁßÀ¸·Î ºÐºñµÈ ´ÙÀ½ ´Ù¸¥ ¼¼Æ÷¿¡ °¡¼­ ¼¼Æ÷ÀÇ ±â´ÉÀ» º¯µ¿½Ã۴ ¹°ÁúÀÇ ÀϺεµ È£¸£¸óÀÇ ¹üÁÖ¿¡ Æ÷ÇÔ½Ã۰í ÀÖÀ¸¸ç À̵éÀ» Æ¯º°È÷ ±¹¼ÒÈ£¸£¸óÀ̶ó ºÎ¸¥´Ù(¿¹-¾Æ¼¼Æ¿Äݸ°, ¾Æµå·¹³¯¸°, ÄÝ·¹½Ã½ºÅäŰ´Ñ µî). ÀÌ¿¡ ºñÇØ¼­ Æ¯Á¤ ³»ºÐºñ»ù¿¡¼­ Ç÷ÁßÀ¸·Î ºÐºñµÇ´Â ÁøÁ¤ÇÑ ÀǹÌÀǠȣ¸£¸óµéÀ» ÀϹÝÈ£¸£¸óÀ̶ó°í ºÎ¸¥´Ù. È£¸£¸óÀ» ÈçÈ÷ 3Á¾ÀÇ ¹«¸®·Î ºÐ·ù¸¦ Çϴµ¥ ¾Æµå·¹³¯¸°À̳ª thyroxine°ú °°ÀÌ ¾Æ¹Ì³ë»êÀÇ À¯µµÃ¼·Î µÈ È£¸£¸óµé(amine derivative), ¸¹Àº ¾Æ¹Ì³ë»êÀ» Àç·á·Î ¸¸µé¾îÁ³°Å³ª ´ç´Ü¹éÀ¸·Î µÈ ´Ü¹éÈ£¸£¸ó(peptide hormone), ±×¸®°í ÄÝ·¹½ºÅ×·ÑÀ» Àç·á·Î ¸¸µé¾îÁø Áö¹æÈ£¸£¸ó(steroid hormone) µîÀ¸·Î ±¸ºÐµÇ¸ç À̵éÀº ´ëü·Î Á¾·ù¿¡ µû¶ó ÀÛ¿ë¸ÞÄ¿´ÏÁòÀ» ´Þ¸®Çϰí ÀÖ´Ù.
¿µ¹® luteinizing hormone(LH) ÇÑ±Û È²Ã¼Çü¼ºÈ£¸£¸ó
¼³¸í   
  ¿©¼ºÀÇ ¿ù°æÀº Á¤ÇØÁø ¼ø¼­¿¡ ÀÇÇØ ÀϾ°Ô µÈ´Ù. ¸ÕÀú ³­Æ÷ÀÚ±ØÈ£¸£¸óÀÌ ³ú¿¡¼­ ºÐºñµÇ¾î ¿©¼ºÀÇ ³­¼Ò¸¦ ÀÚ±ØÇϰԠµÇ¸é ³­Æ÷°¡ Àڱع޾Ơ³­Æ÷È£¸£¸ó(¿¡½ºÆ®·ÎÁ¨)À» ºÐºñÇϰԠµÇ°í À̰ÍÀº ´Ù½Ã µÇ¸ÔÀ̱⠸ÞÄ¿´ÏÁò ÀÇÇØ ³ú¿¡ ÀÛ¿ëÀ» ÇÏ¿© È²Ã¼È­È£¸£¸óÀÌ ³ú¿¡¼­ ºÐºñµÇ°í À̰ÍÀÌ À̸¥¹Ù ÀýÁ¤¿¡ À̸£·¶À» ¶§, ³­Æ÷¿¡¼­ ¹è¶õÀÌ ÀϾ°Ô µÈ´Ù. ÀÌÈÄ ³­Æ÷´Â È²Ã¼·Î º¯ÇϰԠµÇ¸ç, ¹è¶õµÈ ³­ÀÚ°¡ ¼öÁ¤µÇÁö ¾Æ´ÏÇϸé, È²Ã¼´Â È²Ã¼È£¸£¸ó(ÇÁ·Î°Ô½ºÅ×·Ð)À» ºÐºñÇÑ µÚ ÅðÈ­µÇ°í °ð À̾ù°æÀÌ ÀϾ°Ô µÈ´Ù. ÀÌ ÀÏÀº Á¤»óÀûÀΠ´ëºÎºÐÀÇ ¿©¼º¿¡¼­ 28ÀÏÀ» ÁÖ±â·Î ÀϾ¸ç, ´ë°³ È²Ã¼È­È£¸£¸ó ÀýÁ¤ ÀÌÈÄ ¸¶Áö¸·Àº 14ÀϷΠÀÏÁ¤ÇÏ´Ù°í ÇÑ´Ù.
¿µ¹® muscle cell(=muscle fiber) ÇÑ±Û ±ÙÀ°¼¼Æ÷
¼³¸í   
  ±ÙÀ°Àº ¼öÀDZÙ(ÀǽĿ¡ ÀÇÇØ¼­ Á¶ÀýÀÌ °¡´ÉÇÑ ±ÙÀ°: ¿¹¸¦ µé¾î ´Ù¸®, ÆÈ, ¾ó±¼±ÙÀ° µî)°ú ºÒ¼öÀDZÙ(Àǽİú ¹«°üÇϰԠÁ¶ÀýÇÏÁö ¾Ê¾Æµµ ¿òÁ÷À̴ ±ÙÀ°: ¿¹¸¦ µé¾î ½ÉÀå±Ù, ¼ÒÈ­±â°ü¿¡ ºÐÆ÷Çϴ ±ÙÀ° µî)À¸·Î ³ª´©¾îÁö¸ç, ±ÙÀ°¼¼Æ÷ÀÇ ¸ð¾çÀº ´ÙÀ½°ú °°´Ù(¼öÀDZÙ, ºÒ¼öÀDZ٠¿Ü¿¡ ½ÉÀå¿¡ Àִ ½ÉÀå±ÙÀº ºÒ¼öÀDZٿ¡ ÇØ´çÇÏÁö¸¸ ±× ¸ð¾çÀº ¼öÀDZٰú °°¾Æ µû·Î ºÐ·ùÇÑ´Ù).
  
  ±ÙÀ°¼¼Æ÷
¿µ¹® white blood cell(WBC), leukocyte ÇÑ±Û ¹éÇ÷±¸
¼³¸í   
  Ç÷¾×³»¿¡ °ñ¼ö±¸°è¼¼Æ÷¿Í ¸²ÇÁ°è¼¼Æ÷, ´ÜÇÙ±¸°è¼¼Æ÷¸¦ ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ¹éÇ÷±¸ÀÇ Áõ°¡°¡ ÀÖÀ¸¸é ´ë°³ °¨¿°ÀÌ Àְųª, È¤Àº Å»¼öÇö»óÀÌ ÀÖÀ½À» ÀǹÌÇÑ´Ù. ¶ÇÇÑ Áö³ªÄ£ ¹éÇ÷±¸¼öÀÇ °¨¼Ò´Â ÀÎü³» ¸é¿ª±â´ÉÀÌ ¶³¾îÁ® ÀÖÀ½À» ÀǹÌÇϸç, ´Ù¸¥ Áúº´¿¡ ÀÇÇØ ³ªÅ¸³ª´Â ÀÌÂ÷ÀûÀΠÇö»óÀÌ ¾Æ´ÑÁö ²À Áø´ÜÀ» ¹Þ¾Æº¸¾Æ¾ß ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • basophilic adenoma
    È£¿°±â»ùÁ¾
  • eccrine papillary adenoma
    ¿¡Å©¸°À¯µÎ»ùÁ¾
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • gastric adenoma
    À§»ùÁ¾
  • hepatic adenoma
    °£»ùÁ¾
  • lactating adenoma
    Á¥ºÐºñ»ùÁ¾, ¼öÀ¯¼±Á¾
  • nephrogenic adenoma
    ÄáÆÏ±â¿ø»ùÁ¾, ½ÅÀå±â¿ø»ùÁ¾
  • nipple adenoma
    À¯µÎ»ùÁ¾, Á¥²ÀÁö»ùÁ¾
  • oxyphilic adenoma
    È£»ê¼¼Æ÷»ùÁ¾
  • pituitary adenoma
    ³úÇϼöü»ùÁ¾
  • pleomorphic adenoma
    ¿©·¯ÇüÅ»ùÁ¾, ´ÙÇü¼±Á¾
  • polypous adenoma
    Æú¸³¸ð¾ç»ùÁ¾
  • papillary adenoma
    À¯µÎ¸ð¾ç»ùÁ¾
  • prolactin-producing adenoma
    ÇÁ·Î¶ôƾºÐºñ»ùÁ¾
  • prostatic adenoma
    Àü¸³»ùÁ¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • gonadotropin releasing hormone agonist agonist
    »ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸óÀÛ¿ëÁ¦
  • hormone
    È£¸£¸ó
  • adrenocorticotropic hormone
    ºÎ½Å°ÑÁúÀÚ±ØÈ£¸£¸ó
  • antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸ó
  • ectopic hormone
    µý°÷È£¸£¸ó
  • follicle stimulating hormone
    ³­Æ÷ÀÚ±ØÈ£¸£¸ó
  • gonadotropin-releasing hormone
    »ý½Ä»ùÀÚ±ØÈ£¸£¸óºÐºñÈ£¸£¸ó
  • inhibitory hormone
    ¾ïÁ¦È£¸£¸ó
  • luteinizing hormone
    ȲüÇü¼ºÈ£¸£¸ó
  • melanocyte-stimulating hormone
    ¸á¶ó´Ñ¼¼Æ÷ÀÚ±ØÈ£¸£¸ó
  • purified follicle stimulating hormone
    ¼ø¼ö³­Æ÷ÀÚ±ØÈ£¸£¸ó
  • releasing hormone
    À¯¸®È£¸£¸ó
  • thyroid stimulating hormone
    °©»ó»ùÀÚ±ØÈ£¸£¸ó
  • syndrome of inappropriate antidiuretic hormone
    Ç×ÀÌ´¢È£¸£¸óºÎÀûÀýºÐºñÁõÈıº
  • sickle cell anemia
    ³´ÀûÇ÷±¸ºóÇ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • eccrine papillary adenoma
    ¿¡Å©¸°À¯µÎ»ùÁ¾
  • eosinophil adenoma
    È£»ê»ùÁ¾
  • hepatic adenoma
    °£»ùÁ¾
  • lactating adenoma
    ¼öÀ¯»ùÁ¾
  • mast adenoma
    Á¥»ùÁ¾
  • nephrogenic adenoma
    ÄáÆÏÅ¿»ùÁ¾, ½Å¿ø¼º»ùÁ¾
  • oxyphilic adenoma
    È£»ê¼¼Æ÷»ùÁ¾
  • papillary adenoma
    À¯µÎ¸ð¾ç»ùÁ¾
  • parathyroid adenoma
    ºÎ°©»ó»ùÁ¾
  • pituitary adenoma
    ³úÇϼöü»ùÁ¾
  • pleomorphic adenoma
    ¿©·¯ÇüÅ»ùÁ¾
  • polypous adenoma
    Æú¸³¸ð¾ç»ùÁ¾
  • prostatic adenoma
    Àü¸³»ùÁ¾
  • renal adenoma
    ÄáÆÏ»ùÁ¾
  • renal cortical adenoma
    ÄáÆÏ°ÑÁú»ùÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • growth hormone =GH
    ¼ºÀå(à÷íþ)È£¸£¸ó.
  • growth hormone =GH
    ¼ºÀåÈ£¸£¸ó.
  • growth hormone assay
    ¼ºÀåÈ£¸£¸óÃøÁ¤
  • growth hormone-releasing factor
    ¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
  • growth arrest line (=growth recovery line)
    ¼ºÀå Áö¿¬¼±
  • ICSH = interstitial cell stimulating hormone
    °£Áú¼¼Æ÷ÀÚ±Ø(Êàòõá¬øàí©Ð½)È£¸£¸ó.
  • ICSH=£¾interstitial cell stimulating hormone
    °£Áú¼¼Æ÷ÀÚ±ØÈ£¸£¸ó.
  • B cell growth factor
    B ¼¼Æ÷¼ºÀåÀÎÀÚ
  • B cell growth factor (BCGF)
    B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
  • T cell growth factor (TCGF, IL-2)
    T¼¼Æ÷ Áõ½ÄÀÎÀÚ
  • T-cell growth factor
    T-¼¼Æ÷¼ºÀåÀÎÀÚ
  • growth factor, B cell (BCGF)
    B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
  • acidophilic adenoma
    È£»ê¼º¼±Á¾
  • adenoma
    ¼±Á¾(àÍðþ)
  • adenoma sebaceum
    ÇÇÁö¼±Á¾(ù«ò·àÍðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • insulinoma =islet cell adenoma
    µµ¼¼Æ÷Á¾(Óöá¬øàðþ), Àν¶¸°Á¾
  • insuloma =islet cell adenoma
    µµ¼¼Æ÷Á¾(Óöá¬øàðþ), Àν¶¸°Á¾.
  • islet cell adenoma
    µµ¼¼Æ÷¼±Á¾(Óöá¬øààÍðþ)
  • islet cell adenoma =insuloma
    (Ãé)µµ¼¼Æ÷¼±Á¾(Ãéµµ¼¼Æ÷¼±Á¾).
  • islet cell adenoma =insuloma
    (Ãé)µµ¼¼Æ÷¼±Á¾(õýÓöá¬øààÍðþ).
  • islet cell adenoma =insuloma
    (Ãé)µµ¼¼Æ÷¼±Á¾(õý¡­)
  • liver cell adenoma
    °£¼¼Æ÷¼±Á¾(¡­àÊðþ)
  • pancreas,islet cell adenoma
    Ãéµµ¼¼Æ÷¼±Á¾(õýµµá¬øààÍðþ )
  • cell growth
    ¼¼Æ÷¼ºÀå (¡­à÷íþ)
  • cell growth pattern
    ¼¼Æ÷¼ºÀå¸ð¾ç<--¾ç½Ä>
  • cell growth,ligand receptor binding
    ¸®°£µå¼ö¿ë±â°áÇÕ (¡­áôé»ÐïÌ¿ùê)
  • endothelial cell growth factor
    ³»ÇǼ¼Æ÷ Áõ½ÄÀÎÀÚ
  • growth factor, B cell (BCGF)
    B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
  • tumor growth,cell aggreagation in
    ¡­¿¡¼­ ¼¼Æ÷ÀÀÁý(¼¼Æ÷ÀÀ±«)
  • tumor growth,cell cycle and
    ¼¼Æ÷ÁÖ±â¿Í ¡­
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Interstitial cell [Dark cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Interstitial cell [Leydig`s cell]
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Bronchiolar cell [Clara cell]
    ¼¼±â°üÁö¼¼Æ÷
    [¿¾ ¿ë¾î] ºÐºñ¼¼Æ÷
  • Parafollicular cell [Calcitonin cell]
    ¼ÒÆ÷°ç¼¼Æ÷
    [¿¾ ¿ë¾î] ¼ÒÆ÷¹æ¼¼Æ÷
  • Neurolemmal cell [Schwann`s cell]
    ½Å°æÁý¼¼Æ÷
    [¿¾ ¿ë¾î] ½Å°æÃʼ¼Æ÷
  • Alpha cell [Glucagon cell]
    ¾ËÆÄ¼¼Æ÷ [±Û·çÄ«°ï¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾ËÆÄ¼¼Æ÷
  • Dark cell [Norepinephrine cell]
    ¾îµÎ¿î¼¼Æ÷ [³ë¸£¿¡Çdz×ÇÁ¸°¼¼Æ÷]
    [¿¾ ¿ë¾î] ¾Ï¼¼Æ÷(³ë¸£¿¡Çdz×ÇÁ¸°ºÐºñ¼¼Æ÷)
  • Chief cell [Type I glomus cell]
    °ú¸³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁÖ¼¼Æ÷
  • Supporting cell [Sertoli cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁÖ¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷
  • Supporting cell [Type II glomus cell]
    ¹öÆÀ¼¼Æ÷
    [¿¾ ¿ë¾î] ÁöÁö¼¼Æ÷(Á¦2Çü»ç±¸¼¼Æ÷)
  • Striated muscle cell
    °¡·Î¹«´Ì±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] Ⱦ¹®±Ù¼¼Æ÷
  • Sensory epithelial cell
    °¨°¢»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] °¨°¢»óÇǼ¼Æ÷
  • Cortical endocrine cell
    °ÑÁú³»ºÐºñ¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÇÁú³»ºÐºñ¼¼Æ÷
  • Nodal cell
    °áÀý¼¼Æ÷
    [¿¾ ¿ë¾î] °áÀý¼¼Æ÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anchorage independent growth
    °íÁ¤ºñÀÇÁ¸¼º¼ºÀå(ͳïÒÞªëîðíàõà÷íþ)
  • asynchronous growth
    ºñµ¿½Ã¼º ¼ºÀå (ÞªÔÒãÁàõà÷íþ)
  • balanced growth
    ±ÕÇü¼ºÀå(гû¬à÷íþ)
  • chain-growth polymer
    »ç½½½ÅÀå(ãßíþ)ÁßÇÕü(ñìùêô÷)
  • comb growth test
    °è°ü ¼ºÀå½ÃÇè(ͮήà÷íþãËúÐ)
  • confluent growth
    Àü¸é¼ºÀå(îïØüà÷íþ)
  • density-dependent growth
    "¹ÐµµÀÇÁ¸ ¼ºÀå(ÚËÓøëîðíà÷íþ), (ÔÒ) contact inhibition"
  • epidermal growth factor
    Ç¥ÇǼºÀåÀÎÀÚ (øúù«à÷íþì×í­)
  • epithelial growth factor
    »óÇǼºÀåÀÎÀÚ (ß¾ù«à÷íþì×í­)
  • exponential growth
    Áö¼ö ¼ºÀå (ò¦â¦à÷íþ)
  • exponential growth rate constant
    Áö¼ö ¼ºÀå¼Óµµ »ó¼ö (ò¦â¦à÷íþáÜÓøßÈâ¦)
  • fibroblast growth factors
    ¼¶À¯¾Æ¼¼Æ÷ ¼ºÀÚÀÎÀÚ (àéë«ä´á¬øàà÷íþì×í­)
  • growth curve
    ¼ºÀå°î¼± (à÷íþÍØàÊ)
  • growth factor
    ¼ºÀåÀÎÀÚ (à÷íþì×í­)
  • growth medium
    ¼ºÀå¹èÁö (à÷íþÛÆò¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sebaceous adenoma
    ÇÇÁö¼±Á¾
  • hormone
    È£¸£¸ó
  • hormone dependent tumor
    È£¸£¸óÀÇÁ¸¼ºÁ¾¾ç
  • hormone producing tumor
    È£¸£¸ó»ý»êÁ¾¾ç
  • lactogenic hormone
    ÃÖÀ¯È£¸£¸ó
  • luteinizing hormone
    Ȳüȭȣ¸£¸ó, ȲüÇü¼ºÈ£¸£¸ó
  • luteotropic hormone
    ȲüÀÚ±ØÈ£¸£¸ó, ÇâȲüȣ¸£¸ó
  • male hormone
    ³²¼ºÈ£¸£¸ó
  • male sex hormone
    ³²¼ºÈ£¸£¸ó
  • ovarian hormone
    ³­¼ÒÈ£¸£¸ó
  • parathyroid hormone
    ºÎ°©»ó¼±È£¸£¸ó
  • pituitary hormone
    ³úÇϼöüȣ¸£¸ó
  • placental hormone
    ŹݼºÈ£¸£¸ó
  • thyroid hormone
    °©»ó¼±È£¸£¸ó
  • thyrotropic hormone
    °©»ó¼±ÀÚ±ØÈ£¸£¸ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NG nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given
HCA heart cell aggregate; hepatocellular adenoma; home care aide; Hospital Corporation of America; hydro...
ACC accommodation; acetyl coenzyme A carboxylase; acinic cell carcinoma; acute care center; adenoid cyst...
GHRH Growth Hormone Releasing Hormone
GIH Growth hormone release Inhibiting Hormone
  = Somatostatin
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GH-IGF-I growth hormone-insulin-like growth factor I
APA Aldosterone Producing Adenoma
dra Down Regulated in Adenoma
HA Hepatic Adenoma
PA Pleomorphic Adenoma
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • corticotropin-secreting adenoma
    ÄÚ¸£Æ¼ÄÚÆ®·ÎÇÉ ºÐºñ¼º ¼±Á¾
  • cystic adenoma
    ³¶»ó ¼±Á¾
  • eccrine papillary adenoma
    ¿¡Å©¸° À¯µÎ»ó ¼±Á¾
  • eosinophil adenoma
    È£»ê¼º ¼±Á¾
  • malignant adenoma
    ¾Ç¼º ¼±Á¾
  • malignant oxyphilic adenoma
    ¾Ç¼º È£»ê¼º ¼±Á¾
  • malignant pleomorphic adenoma
    ¾Ç¼º ´ÙÇü¼º ¼±Á¾
  • monomorphic adenoma
    ´Ü Çü¼º ¼±Á¾, ´ÜÇü ¼±Á¾
  • renal cortical adenoma
    ½Å ÇÇÁú ¼±Á¾
  • sebaceous adenoma
    ÇÇÁö¼±Á¾
  • serous adenoma
    Àå¾×¼º ¼±Á¾
  • trabecular adenoma
    ¼ÒÁÖ»ó ¼±Á¾
  • tubular adenoma
    °ü»ó ¼±Á¾
  • villous adenoma
    À¶¸ð ¼±Á¾
  • abnormal growth
    ºñÁ¤»ó ¼ºÀå
    ¼ºÀåÀÌ Á¤»óÀûÀÎ ¹üÀ§¸¦ ¹þ¾î³­ »óÅÂ. Á¤»óº¸´Ù »¡¸® ÀÚ¶ö ¼öµµ ÀÖ°í ´Ê°Ô ÀÚ¶ö ¼öµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
follicle-stimulating hormone-releasing hormone A decapeptide of hypothalamic origin capable of accelerating pituitary secretion of follitropin.
Synonym: follicle-stimulating hormone-releasing factor, follicle-stimulating hormone-releasing hormone.
Origin: follicle-stimulating hormone + L. Libero, to free, + -in
(05 Mar 2000)
luteinizing hormone/follicle-stimulating hormone-releasing factor gonadotrophin-releasing hormone
luteinizing hormone-releasing hormone A hormone that controls sex hormones in men and women. Also called lhrh.
(12 Dec 1998)
adenoma, islet cell A benign tumour of the islets of langerhans that may occur anywhere throughout the pancreas. Such tumours may result in hyperinsulinism or zollinger-ellison syndrome.
(12 Dec 1998)
adenoma, liver cell A benign epithelial tumour of the liver.
(12 Dec 1998)
basal cell adenoma <tumour> A benign tumour of major or minor salivary glands or other organs composed of small cells showing peripheral palisading.
(05 Mar 2000)
Hurthle cell adenoma <tumour> An uncommon type of thyroid tumour characterised by abundant eosinophilic cytoplasm containing numerous mitochondria. Often malignant with widespread metastases; rarely takes up radioiodine.
See: Hurthle cell tumour.
(05 Mar 2000)
null-cell adenoma <tumour> An adenoma of the hypophysis composed of cells for which there is no overt evidence or hormone production, but which usually produces hypopituitarism and visual disturbances by compression of adjacent structures; approximately one third of these tumours have cells with abundant mitochondria (oncocytes) that are somewhat larger than the monocytic null cells.
Synonym: undifferentiated cell adenoma.
(05 Mar 2000)
islet cell adenoma <tumour> A benign neoplasm of the pancreas composed of tissue similar in structure to that of the islets of Langerhans; it may contain functioning beta cells, and may cause hypoglycaemia.
See: insulinoma.
Synonym: nesidioblastoma.
(05 Mar 2000)
undifferentiated cell adenoma <tumour> An adenoma of the hypophysis composed of cells for which there is no overt evidence or hormone production, but which usually produces hypopituitarism and visual disturbances by compression of adjacent structures; approximately one third of these tumours have cells with abundant mitochondria (oncocytes) that are somewhat larger than the monocytic null cells.
Synonym: undifferentiated cell adenoma.
(05 Mar 2000)
Leydig cell adenoma <tumour> A small benign tumours of the testis that often produce testosterone, causing endocrine symptoms.
Synonym: interstitial cell tumour of testis.
(05 Mar 2000)
B-cell differentiation/growth factors Various substances, usually obtained from the supernatant of T-cell cultures, such as interleukin 4, 5, and 6. These substances are necessary for B-cell growth, maturation, and differentiation into plasma cells or B memory cells.
(05 Mar 2000)
cell growth <cell biology> Usually used to mean increase in the size of a population of cells though strictly should be reserved for an increase in cytoplasmic volume of an individual cell.
(26 Mar 1998)
haematopoietic cell growth factors These growth factors comprise a family of haematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. Erythropoietin and the colony-stimulating factors belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.
(12 Dec 1998)
stem cell growth factors <growth factor> Compounds, usually proteins, that make stem cells grow faster.
(26 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • negative growth
    (°æÁ¦ÀÇ)¸¶À̳ʽº ¼ºÀå
  • nerve growth factor
    (»ý¸®)½Å°æ ¼ºÀåÀÎÀÚ(Áö°¢(±³°¨)½Å°æ¼¼Æ÷ÀÇ ¼ºÀåÀ» ÀÚ±ØÇÏ´Â ´Ü¹éÁú)
  • positive growth
    Ç÷¯½º ¼ºÀå
  • cell
    ¼¼Æ÷
  • HeLa cell
    Èú·¯ ¼¼Æ÷(¿¬±¸¿ëÀ¸·Î ¹è¾çµÇ°í ÀÖ´Â ¾Ï¼¼Æ÷ÀÇ ÀÏÁ¾)
  • blood cell
    Ç÷±¸
  • brain cell
    ³ú½Å°æ¼¼Æ÷
  • cadmium cell
    Ä«µå¹Å ÀüÁö
  • cell
    ÀÛÀº¹æ;¾ÏÀÚ(¼öµµ¿ø ºÎ¼ÓÀÇ);»ç½Ç;¿ÀµÎ¸·Áý;¹«´ý;(±³µµ¼ÒÀÇ)µ¶¹æ;(¹úÁýÀÇ)±¸¸Û;²É°¡·çÁÖ¸Ó´Ï;ÀüÁö;¼¼Æ÷;(Á¶Á÷³»ÀÇ)ÀÛÀº °øµ¿;¼¼Æ÷(°ø»ê´ç µîÀÇ);°¡½ºÅë(±â±¸ÀÇ);ºñÆ®ÀÇ ±â¾ï¼ÒÀÚ;µ¶¹æ»ìÀÌÇÏ´Ù;ÀÛÀº ¹æ¿¡ Ʋ¾î¹ÚÈ÷´Ù
  • cell body
    ¼¼Æ÷ÀÇ
  • cell cycle
    ¼¼Æ÷ÁÖ±â;ºÐ¿­ÁÖ±â
  • cell division
    ¼¼Æ÷ºÐ¿­
  • cell fusion
    ¼¼Æ÷À¶ÇÕ
  • cell lysis
    ¼¼Æ÷¿ëÇØ
  • cell membrane
    ¼¼Æ÷¸·;¿øÇüÁú¸·;=CELL WALL
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á